Skip to main content
. 2014 Jan 13;2014(1):CD003559. doi: 10.1002/14651858.CD003559.pub4

NCT00139152.

Trial name or title Non‐invasive ways to evaluate lung disease after treatment with Xolair
Methods Randomised, double‐blind, parallel‐group study
Participants People with stable asthma. 12 years of age and older
Interventions Xolair 0.016 mg/kg IgE, SQ versus saline placebo
Outcomes Levels of pH, nitrate/nitrite in exhaled breath condensate before and after four months of treatment
Starting date September 2005
Contact information http://clinicaltrials.gov/ct2/show/NCT00139152
Notes